nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticagrelor—ABCB1—Mitomycin—urinary bladder cancer	0.254	0.379	CbGbCtD
Ticagrelor—CYP3A4—Thiotepa—urinary bladder cancer	0.116	0.172	CbGbCtD
Ticagrelor—ABCB1—Gemcitabine—urinary bladder cancer	0.0733	0.109	CbGbCtD
Ticagrelor—ABCB1—Cisplatin—urinary bladder cancer	0.0532	0.0792	CbGbCtD
Ticagrelor—ABCB1—Etoposide—urinary bladder cancer	0.0523	0.0779	CbGbCtD
Ticagrelor—ABCB1—Doxorubicin—urinary bladder cancer	0.0357	0.0531	CbGbCtD
Ticagrelor—ABCB1—Methotrexate—urinary bladder cancer	0.0346	0.0514	CbGbCtD
Ticagrelor—CYP3A4—Etoposide—urinary bladder cancer	0.0313	0.0466	CbGbCtD
Ticagrelor—CYP3A4—Doxorubicin—urinary bladder cancer	0.0214	0.0318	CbGbCtD
Ticagrelor—P2RY12—prostate gland—urinary bladder cancer	0.00533	0.324	CbGeAlD
Ticagrelor—P2RY12—epithelium—urinary bladder cancer	0.00392	0.238	CbGeAlD
Ticagrelor—CYP3A4—urine—urinary bladder cancer	0.00258	0.157	CbGeAlD
Ticagrelor—ABCB1—prostate gland—urinary bladder cancer	0.000656	0.0399	CbGeAlD
Ticagrelor—CYP3A4—renal system—urinary bladder cancer	0.000632	0.0384	CbGeAlD
Ticagrelor—ABCB1—seminal vesicle—urinary bladder cancer	0.000555	0.0337	CbGeAlD
Ticagrelor—Chest pain—Fluorouracil—urinary bladder cancer	0.000522	0.00167	CcSEcCtD
Ticagrelor—Fatigue—Thiotepa—urinary bladder cancer	0.000521	0.00167	CcSEcCtD
Ticagrelor—Constipation—Thiotepa—urinary bladder cancer	0.000517	0.00166	CcSEcCtD
Ticagrelor—Back pain—Etoposide—urinary bladder cancer	0.000515	0.00165	CcSEcCtD
Ticagrelor—Cardiac failure—Epirubicin—urinary bladder cancer	0.000508	0.00163	CcSEcCtD
Ticagrelor—CYP3A4—female reproductive system—urinary bladder cancer	0.000506	0.0308	CbGeAlD
Ticagrelor—Cardiac failure congestive—Doxorubicin—urinary bladder cancer	0.000505	0.00162	CcSEcCtD
Ticagrelor—Confusional state—Fluorouracil—urinary bladder cancer	0.000504	0.00162	CcSEcCtD
Ticagrelor—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.000499	0.0016	CcSEcCtD
Ticagrelor—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000498	0.0016	CcSEcCtD
Ticagrelor—Renal failure acute—Doxorubicin—urinary bladder cancer	0.000497	0.00159	CcSEcCtD
Ticagrelor—Gastrointestinal haemorrhage—Epirubicin—urinary bladder cancer	0.000495	0.00159	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000495	0.00159	CcSEcCtD
Ticagrelor—Skin disorder—Gemcitabine—urinary bladder cancer	0.000494	0.00158	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.000491	0.00158	CcSEcCtD
Ticagrelor—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.000491	0.00157	CcSEcCtD
Ticagrelor—ABCB1—epithelium—urinary bladder cancer	0.000482	0.0293	CbGeAlD
Ticagrelor—Breast disorder—Methotrexate—urinary bladder cancer	0.000478	0.00153	CcSEcCtD
Ticagrelor—Vertigo—Etoposide—urinary bladder cancer	0.000478	0.00153	CcSEcCtD
Ticagrelor—Abdominal pain—Thiotepa—urinary bladder cancer	0.000478	0.00153	CcSEcCtD
Ticagrelor—Body temperature increased—Thiotepa—urinary bladder cancer	0.000478	0.00153	CcSEcCtD
Ticagrelor—Hypotension—Gemcitabine—urinary bladder cancer	0.000475	0.00152	CcSEcCtD
Ticagrelor—Cardiac failure—Doxorubicin—urinary bladder cancer	0.00047	0.00151	CcSEcCtD
Ticagrelor—Loss of consciousness—Etoposide—urinary bladder cancer	0.000468	0.0015	CcSEcCtD
Ticagrelor—Hypotension—Fluorouracil—urinary bladder cancer	0.000467	0.0015	CcSEcCtD
Ticagrelor—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000465	0.00149	CcSEcCtD
Ticagrelor—Cough—Etoposide—urinary bladder cancer	0.000464	0.00149	CcSEcCtD
Ticagrelor—Blood creatinine increased—Epirubicin—urinary bladder cancer	0.000464	0.00149	CcSEcCtD
Ticagrelor—Skin disorder—Cisplatin—urinary bladder cancer	0.000461	0.00148	CcSEcCtD
Ticagrelor—Hypertension—Etoposide—urinary bladder cancer	0.00046	0.00147	CcSEcCtD
Ticagrelor—Gastrointestinal haemorrhage—Doxorubicin—urinary bladder cancer	0.000458	0.00147	CcSEcCtD
Ticagrelor—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000457	0.00146	CcSEcCtD
Ticagrelor—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000454	0.00145	CcSEcCtD
Ticagrelor—Chest pain—Etoposide—urinary bladder cancer	0.000453	0.00145	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.00045	0.00144	CcSEcCtD
Ticagrelor—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000449	0.00144	CcSEcCtD
Ticagrelor—Breast disorder—Epirubicin—urinary bladder cancer	0.000448	0.00144	CcSEcCtD
Ticagrelor—ABCB1—renal system—urinary bladder cancer	0.000447	0.0272	CbGeAlD
Ticagrelor—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000446	0.00143	CcSEcCtD
Ticagrelor—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000446	0.00143	CcSEcCtD
Ticagrelor—Hypotension—Cisplatin—urinary bladder cancer	0.000443	0.00142	CcSEcCtD
Ticagrelor—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00044	0.00141	CcSEcCtD
Ticagrelor—ABCB1—urethra—urinary bladder cancer	0.000439	0.0267	CbGeAlD
Ticagrelor—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000439	0.00141	CcSEcCtD
Ticagrelor—Fatigue—Gemcitabine—urinary bladder cancer	0.000439	0.00141	CcSEcCtD
Ticagrelor—Gastritis—Epirubicin—urinary bladder cancer	0.000438	0.00141	CcSEcCtD
Ticagrelor—Confusional state—Etoposide—urinary bladder cancer	0.000438	0.0014	CcSEcCtD
Ticagrelor—Constipation—Gemcitabine—urinary bladder cancer	0.000435	0.0014	CcSEcCtD
Ticagrelor—Asthenia—Thiotepa—urinary bladder cancer	0.000434	0.00139	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000432	0.00138	CcSEcCtD
Ticagrelor—Blood creatinine increased—Doxorubicin—urinary bladder cancer	0.000429	0.00138	CcSEcCtD
Ticagrelor—Pruritus—Thiotepa—urinary bladder cancer	0.000428	0.00137	CcSEcCtD
Ticagrelor—Paraesthesia—Cisplatin—urinary bladder cancer	0.000426	0.00137	CcSEcCtD
Ticagrelor—Dyspnoea—Cisplatin—urinary bladder cancer	0.000423	0.00136	CcSEcCtD
Ticagrelor—Skin disorder—Etoposide—urinary bladder cancer	0.000422	0.00135	CcSEcCtD
Ticagrelor—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000419	0.00134	CcSEcCtD
Ticagrelor—Breast disorder—Doxorubicin—urinary bladder cancer	0.000414	0.00133	CcSEcCtD
Ticagrelor—Diarrhoea—Thiotepa—urinary bladder cancer	0.000414	0.00133	CcSEcCtD
Ticagrelor—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000412	0.00132	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000409	0.00131	CcSEcCtD
Ticagrelor—Hypotension—Etoposide—urinary bladder cancer	0.000406	0.0013	CcSEcCtD
Ticagrelor—Gastritis—Doxorubicin—urinary bladder cancer	0.000406	0.0013	CcSEcCtD
Ticagrelor—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000402	0.00129	CcSEcCtD
Ticagrelor—Dizziness—Thiotepa—urinary bladder cancer	0.0004	0.00128	CcSEcCtD
Ticagrelor—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000395	0.00127	CcSEcCtD
Ticagrelor—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000391	0.00125	CcSEcCtD
Ticagrelor—Paraesthesia—Etoposide—urinary bladder cancer	0.00039	0.00125	CcSEcCtD
Ticagrelor—Haematuria—Methotrexate—urinary bladder cancer	0.000389	0.00125	CcSEcCtD
Ticagrelor—Dyspnoea—Etoposide—urinary bladder cancer	0.000387	0.00124	CcSEcCtD
Ticagrelor—Epistaxis—Methotrexate—urinary bladder cancer	0.000385	0.00123	CcSEcCtD
Ticagrelor—Vomiting—Thiotepa—urinary bladder cancer	0.000385	0.00123	CcSEcCtD
Ticagrelor—Rash—Thiotepa—urinary bladder cancer	0.000381	0.00122	CcSEcCtD
Ticagrelor—Dermatitis—Thiotepa—urinary bladder cancer	0.000381	0.00122	CcSEcCtD
Ticagrelor—Headache—Thiotepa—urinary bladder cancer	0.000379	0.00121	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000375	0.0012	CcSEcCtD
Ticagrelor—Body temperature increased—Cisplatin—urinary bladder cancer	0.000375	0.0012	CcSEcCtD
Ticagrelor—Fatigue—Etoposide—urinary bladder cancer	0.000375	0.0012	CcSEcCtD
Ticagrelor—Constipation—Etoposide—urinary bladder cancer	0.000371	0.00119	CcSEcCtD
Ticagrelor—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000369	0.00118	CcSEcCtD
Ticagrelor—Haemoglobin—Methotrexate—urinary bladder cancer	0.000368	0.00118	CcSEcCtD
Ticagrelor—Haemorrhage—Methotrexate—urinary bladder cancer	0.000366	0.00117	CcSEcCtD
Ticagrelor—Asthenia—Gemcitabine—urinary bladder cancer	0.000365	0.00117	CcSEcCtD
Ticagrelor—Haematuria—Epirubicin—urinary bladder cancer	0.000364	0.00117	CcSEcCtD
Ticagrelor—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000362	0.00116	CcSEcCtD
Ticagrelor—Epistaxis—Epirubicin—urinary bladder cancer	0.00036	0.00115	CcSEcCtD
Ticagrelor—Pruritus—Gemcitabine—urinary bladder cancer	0.00036	0.00115	CcSEcCtD
Ticagrelor—Nausea—Thiotepa—urinary bladder cancer	0.000359	0.00115	CcSEcCtD
Ticagrelor—Urethral disorder—Methotrexate—urinary bladder cancer	0.000359	0.00115	CcSEcCtD
Ticagrelor—ABCB1—female reproductive system—urinary bladder cancer	0.000358	0.0218	CbGeAlD
Ticagrelor—Feeling abnormal—Etoposide—urinary bladder cancer	0.000358	0.00115	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000355	0.00114	CcSEcCtD
Ticagrelor—Pruritus—Fluorouracil—urinary bladder cancer	0.000354	0.00113	CcSEcCtD
Ticagrelor—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000349	0.00112	CcSEcCtD
Ticagrelor—Bradycardia—Epirubicin—urinary bladder cancer	0.000349	0.00112	CcSEcCtD
Ticagrelor—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000348	0.00112	CcSEcCtD
Ticagrelor—Haemoglobin—Epirubicin—urinary bladder cancer	0.000344	0.0011	CcSEcCtD
Ticagrelor—Abdominal pain—Etoposide—urinary bladder cancer	0.000343	0.0011	CcSEcCtD
Ticagrelor—Body temperature increased—Etoposide—urinary bladder cancer	0.000343	0.0011	CcSEcCtD
Ticagrelor—Haemorrhage—Epirubicin—urinary bladder cancer	0.000343	0.0011	CcSEcCtD
Ticagrelor—Eye disorder—Methotrexate—urinary bladder cancer	0.000342	0.0011	CcSEcCtD
Ticagrelor—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000342	0.0011	CcSEcCtD
Ticagrelor—Asthenia—Cisplatin—urinary bladder cancer	0.00034	0.00109	CcSEcCtD
Ticagrelor—Cardiac disorder—Methotrexate—urinary bladder cancer	0.00034	0.00109	CcSEcCtD
Ticagrelor—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000338	0.00109	CcSEcCtD
Ticagrelor—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000338	0.00108	CcSEcCtD
Ticagrelor—Haematuria—Doxorubicin—urinary bladder cancer	0.000337	0.00108	CcSEcCtD
Ticagrelor—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000337	0.00108	CcSEcCtD
Ticagrelor—Urethral disorder—Epirubicin—urinary bladder cancer	0.000336	0.00108	CcSEcCtD
Ticagrelor—Epistaxis—Doxorubicin—urinary bladder cancer	0.000333	0.00107	CcSEcCtD
Ticagrelor—Angiopathy—Methotrexate—urinary bladder cancer	0.000332	0.00107	CcSEcCtD
Ticagrelor—Immune system disorder—Methotrexate—urinary bladder cancer	0.000331	0.00106	CcSEcCtD
Ticagrelor—Dizziness—Fluorouracil—urinary bladder cancer	0.000331	0.00106	CcSEcCtD
Ticagrelor—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.00033	0.00106	CcSEcCtD
Ticagrelor—Diarrhoea—Cisplatin—urinary bladder cancer	0.000324	0.00104	CcSEcCtD
Ticagrelor—ABCB1—vagina—urinary bladder cancer	0.000324	0.0197	CbGeAlD
Ticagrelor—Vomiting—Gemcitabine—urinary bladder cancer	0.000323	0.00104	CcSEcCtD
Ticagrelor—Bradycardia—Doxorubicin—urinary bladder cancer	0.000323	0.00104	CcSEcCtD
Ticagrelor—Mental disorder—Methotrexate—urinary bladder cancer	0.000321	0.00103	CcSEcCtD
Ticagrelor—Rash—Gemcitabine—urinary bladder cancer	0.000321	0.00103	CcSEcCtD
Ticagrelor—Dermatitis—Gemcitabine—urinary bladder cancer	0.00032	0.00103	CcSEcCtD
Ticagrelor—Eye disorder—Epirubicin—urinary bladder cancer	0.00032	0.00103	CcSEcCtD
Ticagrelor—Hypersensitivity—Etoposide—urinary bladder cancer	0.00032	0.00103	CcSEcCtD
Ticagrelor—Malnutrition—Methotrexate—urinary bladder cancer	0.000319	0.00102	CcSEcCtD
Ticagrelor—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000319	0.00102	CcSEcCtD
Ticagrelor—Headache—Gemcitabine—urinary bladder cancer	0.000319	0.00102	CcSEcCtD
Ticagrelor—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000318	0.00102	CcSEcCtD
Ticagrelor—Vomiting—Fluorouracil—urinary bladder cancer	0.000318	0.00102	CcSEcCtD
Ticagrelor—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000317	0.00102	CcSEcCtD
Ticagrelor—Rash—Fluorouracil—urinary bladder cancer	0.000315	0.00101	CcSEcCtD
Ticagrelor—Dermatitis—Fluorouracil—urinary bladder cancer	0.000315	0.00101	CcSEcCtD
Ticagrelor—Headache—Fluorouracil—urinary bladder cancer	0.000313	0.001	CcSEcCtD
Ticagrelor—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000313	0.001	CcSEcCtD
Ticagrelor—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000312	0.001	CcSEcCtD
Ticagrelor—Asthenia—Etoposide—urinary bladder cancer	0.000312	0.001	CcSEcCtD
Ticagrelor—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000312	0.000999	CcSEcCtD
Ticagrelor—Angiopathy—Epirubicin—urinary bladder cancer	0.000311	0.000997	CcSEcCtD
Ticagrelor—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000311	0.000997	CcSEcCtD
Ticagrelor—Immune system disorder—Epirubicin—urinary bladder cancer	0.00031	0.000993	CcSEcCtD
Ticagrelor—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000309	0.000991	CcSEcCtD
Ticagrelor—Back pain—Methotrexate—urinary bladder cancer	0.000308	0.000989	CcSEcCtD
Ticagrelor—Pruritus—Etoposide—urinary bladder cancer	0.000307	0.000986	CcSEcCtD
Ticagrelor—Nausea—Gemcitabine—urinary bladder cancer	0.000302	0.000969	CcSEcCtD
Ticagrelor—Vomiting—Cisplatin—urinary bladder cancer	0.000301	0.000967	CcSEcCtD
Ticagrelor—Mental disorder—Epirubicin—urinary bladder cancer	0.0003	0.000963	CcSEcCtD
Ticagrelor—Rash—Cisplatin—urinary bladder cancer	0.000299	0.000959	CcSEcCtD
Ticagrelor—Dermatitis—Cisplatin—urinary bladder cancer	0.000299	0.000958	CcSEcCtD
Ticagrelor—Malnutrition—Epirubicin—urinary bladder cancer	0.000298	0.000957	CcSEcCtD
Ticagrelor—Diarrhoea—Etoposide—urinary bladder cancer	0.000297	0.000953	CcSEcCtD
Ticagrelor—Nausea—Fluorouracil—urinary bladder cancer	0.000297	0.000953	CcSEcCtD
Ticagrelor—Eye disorder—Doxorubicin—urinary bladder cancer	0.000296	0.00095	CcSEcCtD
Ticagrelor—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000294	0.000944	CcSEcCtD
Ticagrelor—Back pain—Epirubicin—urinary bladder cancer	0.000289	0.000926	CcSEcCtD
Ticagrelor—Angiopathy—Doxorubicin—urinary bladder cancer	0.000288	0.000923	CcSEcCtD
Ticagrelor—Dizziness—Etoposide—urinary bladder cancer	0.000287	0.000921	CcSEcCtD
Ticagrelor—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000286	0.000919	CcSEcCtD
Ticagrelor—Vertigo—Methotrexate—urinary bladder cancer	0.000286	0.000919	CcSEcCtD
Ticagrelor—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000286	0.000917	CcSEcCtD
Ticagrelor—Nausea—Cisplatin—urinary bladder cancer	0.000282	0.000903	CcSEcCtD
Ticagrelor—Cough—Methotrexate—urinary bladder cancer	0.000278	0.000892	CcSEcCtD
Ticagrelor—Mental disorder—Doxorubicin—urinary bladder cancer	0.000278	0.000891	CcSEcCtD
Ticagrelor—Vomiting—Etoposide—urinary bladder cancer	0.000276	0.000886	CcSEcCtD
Ticagrelor—Malnutrition—Doxorubicin—urinary bladder cancer	0.000276	0.000885	CcSEcCtD
Ticagrelor—Rash—Etoposide—urinary bladder cancer	0.000274	0.000878	CcSEcCtD
Ticagrelor—Dermatitis—Etoposide—urinary bladder cancer	0.000274	0.000878	CcSEcCtD
Ticagrelor—Headache—Etoposide—urinary bladder cancer	0.000272	0.000873	CcSEcCtD
Ticagrelor—Chest pain—Methotrexate—urinary bladder cancer	0.000271	0.00087	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.00027	0.000864	CcSEcCtD
Ticagrelor—Vertigo—Epirubicin—urinary bladder cancer	0.000268	0.00086	CcSEcCtD
Ticagrelor—Syncope—Epirubicin—urinary bladder cancer	0.000268	0.000858	CcSEcCtD
Ticagrelor—Back pain—Doxorubicin—urinary bladder cancer	0.000267	0.000856	CcSEcCtD
Ticagrelor—Confusional state—Methotrexate—urinary bladder cancer	0.000262	0.000841	CcSEcCtD
Ticagrelor—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000262	0.000841	CcSEcCtD
Ticagrelor—Cough—Epirubicin—urinary bladder cancer	0.00026	0.000835	CcSEcCtD
Ticagrelor—Nausea—Etoposide—urinary bladder cancer	0.000258	0.000827	CcSEcCtD
Ticagrelor—Hypertension—Epirubicin—urinary bladder cancer	0.000258	0.000826	CcSEcCtD
Ticagrelor—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000255	0.000818	CcSEcCtD
Ticagrelor—Chest pain—Epirubicin—urinary bladder cancer	0.000254	0.000815	CcSEcCtD
Ticagrelor—Skin disorder—Methotrexate—urinary bladder cancer	0.000253	0.000811	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000252	0.000809	CcSEcCtD
Ticagrelor—Vertigo—Doxorubicin—urinary bladder cancer	0.000248	0.000795	CcSEcCtD
Ticagrelor—Syncope—Doxorubicin—urinary bladder cancer	0.000248	0.000794	CcSEcCtD
Ticagrelor—Confusional state—Epirubicin—urinary bladder cancer	0.000246	0.000787	CcSEcCtD
Ticagrelor—Hypotension—Methotrexate—urinary bladder cancer	0.000243	0.00078	CcSEcCtD
Ticagrelor—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000243	0.000778	CcSEcCtD
Ticagrelor—Cough—Doxorubicin—urinary bladder cancer	0.000241	0.000773	CcSEcCtD
Ticagrelor—Shock—Epirubicin—urinary bladder cancer	0.00024	0.000768	CcSEcCtD
Ticagrelor—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000239	0.000766	CcSEcCtD
Ticagrelor—Hypertension—Doxorubicin—urinary bladder cancer	0.000238	0.000764	CcSEcCtD
Ticagrelor—Skin disorder—Epirubicin—urinary bladder cancer	0.000237	0.000759	CcSEcCtD
Ticagrelor—Chest pain—Doxorubicin—urinary bladder cancer	0.000235	0.000754	CcSEcCtD
Ticagrelor—Paraesthesia—Methotrexate—urinary bladder cancer	0.000234	0.000749	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000233	0.000749	CcSEcCtD
Ticagrelor—Dyspnoea—Methotrexate—urinary bladder cancer	0.000232	0.000744	CcSEcCtD
Ticagrelor—Dyspepsia—Methotrexate—urinary bladder cancer	0.000229	0.000735	CcSEcCtD
Ticagrelor—Hypotension—Epirubicin—urinary bladder cancer	0.000228	0.00073	CcSEcCtD
Ticagrelor—Confusional state—Doxorubicin—urinary bladder cancer	0.000227	0.000729	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000225	0.00072	CcSEcCtD
Ticagrelor—Fatigue—Methotrexate—urinary bladder cancer	0.000224	0.000719	CcSEcCtD
Ticagrelor—Shock—Doxorubicin—urinary bladder cancer	0.000222	0.000711	CcSEcCtD
Ticagrelor—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000221	0.000709	CcSEcCtD
Ticagrelor—Skin disorder—Doxorubicin—urinary bladder cancer	0.000219	0.000702	CcSEcCtD
Ticagrelor—Paraesthesia—Epirubicin—urinary bladder cancer	0.000219	0.000701	CcSEcCtD
Ticagrelor—Dyspnoea—Epirubicin—urinary bladder cancer	0.000217	0.000696	CcSEcCtD
Ticagrelor—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000214	0.000688	CcSEcCtD
Ticagrelor—Dyspepsia—Epirubicin—urinary bladder cancer	0.000214	0.000687	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000213	0.000682	CcSEcCtD
Ticagrelor—Hypotension—Doxorubicin—urinary bladder cancer	0.000211	0.000675	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.00021	0.000674	CcSEcCtD
Ticagrelor—Fatigue—Epirubicin—urinary bladder cancer	0.00021	0.000673	CcSEcCtD
Ticagrelor—ABCB1—lymph node—urinary bladder cancer	0.000209	0.0127	CbGeAlD
Ticagrelor—Constipation—Epirubicin—urinary bladder cancer	0.000208	0.000668	CcSEcCtD
Ticagrelor—Body temperature increased—Methotrexate—urinary bladder cancer	0.000206	0.00066	CcSEcCtD
Ticagrelor—Abdominal pain—Methotrexate—urinary bladder cancer	0.000206	0.00066	CcSEcCtD
Ticagrelor—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000202	0.000649	CcSEcCtD
Ticagrelor—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000201	0.000644	CcSEcCtD
Ticagrelor—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000201	0.000644	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000199	0.000639	CcSEcCtD
Ticagrelor—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000198	0.000636	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000195	0.000624	CcSEcCtD
Ticagrelor—Fatigue—Doxorubicin—urinary bladder cancer	0.000194	0.000623	CcSEcCtD
Ticagrelor—Constipation—Doxorubicin—urinary bladder cancer	0.000193	0.000618	CcSEcCtD
Ticagrelor—Abdominal pain—Epirubicin—urinary bladder cancer	0.000192	0.000617	CcSEcCtD
Ticagrelor—Body temperature increased—Epirubicin—urinary bladder cancer	0.000192	0.000617	CcSEcCtD
Ticagrelor—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000192	0.000615	CcSEcCtD
Ticagrelor—Asthenia—Methotrexate—urinary bladder cancer	0.000187	0.000599	CcSEcCtD
Ticagrelor—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000186	0.000595	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000184	0.000591	CcSEcCtD
Ticagrelor—Pruritus—Methotrexate—urinary bladder cancer	0.000184	0.00059	CcSEcCtD
Ticagrelor—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000179	0.000575	CcSEcCtD
Ticagrelor—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000178	0.000571	CcSEcCtD
Ticagrelor—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000178	0.000571	CcSEcCtD
Ticagrelor—Diarrhoea—Methotrexate—urinary bladder cancer	0.000178	0.000571	CcSEcCtD
Ticagrelor—Asthenia—Epirubicin—urinary bladder cancer	0.000175	0.00056	CcSEcCtD
Ticagrelor—Pruritus—Epirubicin—urinary bladder cancer	0.000172	0.000552	CcSEcCtD
Ticagrelor—Dizziness—Methotrexate—urinary bladder cancer	0.000172	0.000552	CcSEcCtD
Ticagrelor—Diarrhoea—Epirubicin—urinary bladder cancer	0.000167	0.000534	CcSEcCtD
Ticagrelor—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000166	0.000532	CcSEcCtD
Ticagrelor—Vomiting—Methotrexate—urinary bladder cancer	0.000165	0.000531	CcSEcCtD
Ticagrelor—Rash—Methotrexate—urinary bladder cancer	0.000164	0.000526	CcSEcCtD
Ticagrelor—Dermatitis—Methotrexate—urinary bladder cancer	0.000164	0.000526	CcSEcCtD
Ticagrelor—Headache—Methotrexate—urinary bladder cancer	0.000163	0.000523	CcSEcCtD
Ticagrelor—Asthenia—Doxorubicin—urinary bladder cancer	0.000162	0.000518	CcSEcCtD
Ticagrelor—Dizziness—Epirubicin—urinary bladder cancer	0.000161	0.000516	CcSEcCtD
Ticagrelor—Pruritus—Doxorubicin—urinary bladder cancer	0.000159	0.000511	CcSEcCtD
Ticagrelor—Vomiting—Epirubicin—urinary bladder cancer	0.000155	0.000497	CcSEcCtD
Ticagrelor—Nausea—Methotrexate—urinary bladder cancer	0.000155	0.000496	CcSEcCtD
Ticagrelor—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000154	0.000494	CcSEcCtD
Ticagrelor—Rash—Epirubicin—urinary bladder cancer	0.000154	0.000492	CcSEcCtD
Ticagrelor—Dermatitis—Epirubicin—urinary bladder cancer	0.000153	0.000492	CcSEcCtD
Ticagrelor—Headache—Epirubicin—urinary bladder cancer	0.000153	0.000489	CcSEcCtD
Ticagrelor—Dizziness—Doxorubicin—urinary bladder cancer	0.000149	0.000478	CcSEcCtD
Ticagrelor—Nausea—Epirubicin—urinary bladder cancer	0.000145	0.000464	CcSEcCtD
Ticagrelor—Vomiting—Doxorubicin—urinary bladder cancer	0.000143	0.000459	CcSEcCtD
Ticagrelor—Rash—Doxorubicin—urinary bladder cancer	0.000142	0.000456	CcSEcCtD
Ticagrelor—Dermatitis—Doxorubicin—urinary bladder cancer	0.000142	0.000455	CcSEcCtD
Ticagrelor—Headache—Doxorubicin—urinary bladder cancer	0.000141	0.000453	CcSEcCtD
Ticagrelor—Nausea—Doxorubicin—urinary bladder cancer	0.000134	0.000429	CcSEcCtD
